fda warning letters compounded semaglutide tirzepatide september 2025 versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said FDA telehealth crackdown highlights role

J., & Lee, C

Book Now IGF-1 LR3 (1 mg vial) injection from AMIV promotes muscle development, recovery, fat metabolism, and overall vitality

Recent nutraceutical advancements suggest that certain probiotics, peptides, and herbal extracts can naturally boost GLP-1 levels, providing a non-pharmacological pathway to metabolic health

Prescription by Algorithm: The Ethical and Legal Questions Behind GLP-1 Advertising An influencer pitch for a GLP-1 weight-loss drug revealed a troubling shift in how prescriptions are marketed and obtained online

It starts pulling back receptors

Research peptides are sold for research purposes only, not approved by Health Canada for human consumption